TLRY
TLRY
NASDAQ · Pharmaceuticals

Tilray Brands Inc

$4.73
-0.02 (-0.42%)
As of Jun 21, 10:14 PM ET ·
Analyst Consensus
Hold
17
Analysts
High
Coverage
Buy 8 47%
Hold 9 53%
Sell 0 0%
Price Target
Analyst Price Target +794.7% upside
Low Target $27.22
Average Target $42.32
High Target $56.32
Current Price $4.73
Current
$4.73
Target
$42.32
$27.22 $42.32 avg $56.32
Scenario Analysis
Bear Case
$27.22
475.5%
Low target
Base Case
$42.32
+794.7%
Avg target
Bull Case
$56.32
+1,090.7%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$23.20
-79.6% from high
52-Week Low
$3.51
+34.8% from low
Target vs 52W High
$42.32
+82.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%